Frequently Asked Questions Is headache a common side effect of compounded semaglutide
Although still relatively new to the market, studies are beginning to indicate a decreased risk of death from cardiovascular events and kidney disease in people with Type 2 diabetes who took GLP-1 RAs
(PubMed) Singh RB, Niaz MA, Kumar A, Sindberg CD, Moesgaard S, Littarru GP
Record R&D Investment In 2024, global biopharma R&D spending soared to $102 billion a 10-year high up from $71 billion in 2023 underscoring renewed investor confidence in late-stage pipelines
These side effects are generally mild and manageable
Many clients prefer injections for convenience, absorption consistency and predictable dosing